-
Quality of life assessment in patients with Parkinson’s disease
-
Quality of Life in Parkinson’s Disease Patients with Sleep Disturbances
-
Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study
-
Quantification of an Upper Limb Rigidity Network in Parkinson Disease
-
Quantification of Neuroinflammation and White Matter Injury in Parkinson Disease Using Diffusion Basis Spectrum Imaging
-
Quantitative Analysis of the Biomechanical Contributors during the miniBEST Clinical Scale for Assessing Risk of Falling in Parkinson’s Disease
-
Quantitative Assessment of X-linked Dystonia-Parkinsonism Using Wearable Sensing Technology
-
Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson’s Disease
-
RAB32 c.213C>G (p.Ser71Arg) explains Parkinson’s disease in two UK families: description of the clinical and biochemical features
-
RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD)
- « Previous Page
- 1
- …
- 135
- 136
- 137
- 138
- 139
- …
- 181
- Next Page »